Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-011575
Filing Date
2025-08-14
Accepted
2025-08-14 16:21:09
Documents
87
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ipsc-20250630x10q.htm   iXBRL 10-Q 1865930
2 EX-31.1 ipsc-20250630xex31d1.htm EX-31.1 14032
3 EX-31.2 ipsc-20250630xex31d2.htm EX-31.2 13882
4 EX-32.1 ipsc-20250630xex32d1.htm EX-32.1 6874
5 EX-32.2 ipsc-20250630xex32d2.htm EX-32.2 6882
  Complete submission text file 0001558370-25-011575.txt   8994619

Data Files

Seq Description Document Type Size
6 EX-101.SCH ipsc-20250630.xsd EX-101.SCH 59222
7 EX-101.CAL ipsc-20250630_cal.xml EX-101.CAL 69988
8 EX-101.DEF ipsc-20250630_def.xml EX-101.DEF 246876
9 EX-101.LAB ipsc-20250630_lab.xml EX-101.LAB 552554
10 EX-101.PRE ipsc-20250630_pre.xml EX-101.PRE 427681
90 EXTRACTED XBRL INSTANCE DOCUMENT ipsc-20250630x10q_htm.xml XML 1636181
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

EIN.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40498 | Film No.: 251219610
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)